Skye BioscienceSKYE
那斯達克 · USD
2.21
+0.33
(+17.55%)
盤中 09/10 03:41 (UTC+8)
09/10 03:41 (UTC+8)
Skye BioscienceSKYE
2.21
+0.33
(+17.55%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 11,061 | 12,675 | 14,895 | 13,264 | 18,244 | 11,759 | 10,666 | 4,968 | - | - |
研發費用 | 3,942 | 7,936 | 11,469 | 9,357 | 14,338 | 7,197 | 7,793 | 4,883 | 4,079 | 1,946 |
推銷及管理費用 | 7,119 | 4,739 | 3,426 | 3,907 | 3,906 | 4,562 | 2,873 | 85 | 4,327 | 4,206 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -7,811 | -12,674 | -14,896 | -13,265 | -18,244 | -11,760 | -10,666 | -4,969 | -8,406 | -6,152 |
其他收入及費用 | 281 | 167 | 454 | 510 | 621 | 660 | 873 | 980 | 961 | 1,572 |
利息費用 | 3 | 2 | - | - | -1 | 1 | 749 | -887 | 450 | 437 |
稅前純益 | -10,783 | -12,509 | -14,442 | -12,755 | -17,621 | -11,101 | -9,746 | -3,898 | -7,895 | -5,018 |
所得稅 | 3 | - | - | - | 3 | 2 | - | - | 8 | 2 |
稅後純益 | -10,787 | -12,509 | -14,442 | -12,755 | -17,625 | -11,103 | -9,746 | -3,898 | -7,903 | -5,020 |
基本每股稅後盈餘(元) | -0.03 | -0.32 | -0.36 | -0.32 | -0.44 | -0.28 | -0.24 | -0.10 | -0.20 | -0.18 |
稀釋每股稅後盈餘(元) | -0.27 | -0.32 | -0.36 | -0.33 | -0.44 | -0.28 | -0.25 | -0.09 | -0.21 | -0.18 |
基本平均股數(千股) | 317553.00 | 39681.00 | 39673.00 | 39665.00 | 39659.00 | 39651.00 | 39968.00 | 38819.00 | 38669.00 | 27999.00 |
稀釋平均股數(千股) | 317553.00 | 39681.00 | 39673.00 | 39665.00 | 39659.00 | 39651.00 | 39968.00 | 38819.00 | 38669.00 | 27999.00 |
還原基本每股稅後盈餘(元) | -0.27 | -2.56 | -2.88 | -2.56 | -3.52 | -2.24 | -1.92 | -0.80 | -1.60 | -1.44 |
還原稀釋每股稅後盈餘(元) | -2.16 | -2.56 | -2.88 | -2.64 | -3.52 | -2.24 | -2.00 | -0.72 | -1.68 | -1.44 |
還原基本平均股數(千股) | 39,694 | 4,960 | 4,959 | 4,958 | 4,957 | 4,956 | 4,996 | 4,852 | 4,833 | 3,499 |
還原稀釋平均股數(千股) | 39,694 | 4,960 | 4,959 | 4,958 | 4,957 | 4,956 | 4,996 | 4,852 | 4,833 | 3,499 |
EBITDA(千元) | -10,623 | -12,334 | -14,262 | -12,576 | -17,436 | -10,923 | -8,822 | -4,608 | -7,165 | -4,316 |